HealthSouth Risk/Reward Profile Grows Worse


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Barclays' Joshua Raskin has downgraded HealthSouth Corp (NYSE: HLS) to Underweight from Equal Weight on unfavorable risk/reward.

Following are Raskin's seven reasons for the downgrade:

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

    1. "We believe there is increasing scrutiny around IRF payments in the Medicare program, including updated MedPAC pressures."
    2. "Medicare Advantage historically has not utilized services at HealthSouth at the same rate as Medicare FFS."
    3. "Acquisitions continue to obscure unimpressive organic growth for the IRF segment."
    4. "Leverage is up substantially over the past 1.5 years as a result of the company's recent acquisitions of CareSouth, Reliant and Encompass."
    5. "We believe the cross-selling opportunity between the inpatient rehab segment and home-health segment is overstated."
    6. "Based on HealthSouth's current valuation and our outlook for 2016 and 2017, we believe there is little room for multiple expansion."
    7. "We believe the CJR payment model presents a potential risk for HealthSouth."

Meanwhile, Raskin has cut the price target by $3 to $42, while maintaining the full-year EPS at $2.45.

At the time of writing, shares of HealthSouth fell 3.13 percent to $38.32.


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: Analyst ColorShort IdeasDowngradesHealth CarePrice TargetAnalyst RatingsTrading IdeasGeneralBarclaysJoshua Raskin